Intermedix completes acquisition of WPC Healthcare

Intermedix - WPC Healthcare

Intermedix Corporation has completed its acquisition of WPC Healthcare to expand its data science capabilities.

Two years ago, Intermedix announced the creation of its analytics business unit designed to identify key trends across quality, clinical, operational, utilization and financial metrics with the ultimate goal of improving provider performance, quality of care and organizational operations. The addition of WPC Healthcare enhances that objective with the addition of machine learning and predictive analytics solutions focused on improving clinical and financial outcomes.

“Data science and machine learning are the future of healthcare,” Joel Portice, CEO of Intermedix, said in a statement. “The addition of WPC to our suite of solutions is a testament to our company’s commitment to further our investment in healthcare data analytics in order to assist our customers in managing care and optimizing their revenue cycle.”

Nashville, Tennessee-based WPC Healthcare is a data analytics company that uses machine learning to make predictions about healthcare conditions providing early notification to healthcare providers and, ultimately, saving lives while decreasing costs.

“By joining Intermedix, we now have the right partner to take our expertise to market and share our solutions on a much wider scale,” said Ray Guzman, CEO of WPC.

Guzman has led WPC since 2014 and the following year the organization became an independent company after a buyout from Seattle-based Washington Publishing Company. He will join Intermedix as senior vice president of strategy reporting to Joel Portice.

The WPC data science team will join the business analysts and data scientists from Intermedix at the company’s headquarters and innovation lab in Nashville.